# obesity

> medical condition in which individuals have an excess of body fat

**Wikidata**: [Q12174](https://www.wikidata.org/wiki/Q12174)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/Obesity)  
**Source**: https://4ort.xyz/entity/obesity

## Summary
Obesity is a medical condition characterized by an excess of body fat, which can negatively impact health. It is classified as a disease and is linked to overnutrition, with specific subtypes including morbid obesity, childhood obesity, and abdominal obesity. The condition is studied within the academic discipline of medicine, with contributions from figures like John Yudkin and organizations such as Hoffmann-La Roche.

## Key Facts
- Obesity is a medical condition involving an excess of body fat.
- It is classified as a disease and is related to overnutrition.
- Specific subtypes include morbid obesity, obesity in pets, childhood obesity, and abdominal obesity.
- The academic discipline of medicine studies obesity, with contributions from figures like John Yudkin.
- Hoffmann-La Roche is a Swiss healthcare company involved in obesity-related research.
- Obesity has aliases such as corpulence, overfatness, fatness, and obese.
- The condition is part of the broader category of diseases affecting organisms.

## FAQs
**What is the relationship between obesity and overnutrition?**
Obesity is linked to overnutrition, a form of malnutrition where nutrient intake exceeds requirements. Both conditions involve excessive fat accumulation but differ in their underlying causes.

**Who are the notable figures associated with obesity research?**
John Yudkin, a British physiologist, has contributed to obesity research. His work has helped advance understanding of the condition.

**What are the different types of obesity?**
Obesity includes subtypes such as morbid obesity, childhood obesity, abdominal obesity, and obesity in pets. Each subtype has distinct health implications and risk factors.

**Which organizations are involved in obesity research?**
Hoffmann-La Roche, a Swiss healthcare company, is involved in obesity-related research. The company’s work contributes to medical advancements in the field.

## Why It Matters
Obesity is a significant medical condition that affects millions worldwide, impacting health outcomes and quality of life. It is studied within the academic discipline of medicine, with contributions from researchers like John Yudkin. Organizations such as Hoffmann-La Roche play a role in developing treatments and interventions. Understanding obesity is crucial for public health strategies and medical research.

## Notable For
- Being classified as a disease, obesity is recognized as an abnormal condition negatively affecting organisms.
- It is linked to overnutrition, a condition where nutrient intake exceeds requirements.
- Obesity includes specific subtypes like morbid obesity, childhood obesity, and abdominal obesity, each with unique health implications.
- Hoffmann-La Roche’s involvement in obesity research highlights the company’s contribution to medical advancements.

## Body
### Classification and Types
Obesity is classified as a disease, affecting organisms negatively. It is linked to overnutrition, a form of malnutrition where nutrient intake exceeds requirements. Specific subtypes include morbid obesity, childhood obesity, and abdominal obesity, each with distinct characteristics and health impacts.

### Academic and Research Contributions
The academic discipline of medicine studies obesity, with contributions from figures like John Yudkin. His work has advanced understanding of the condition. Hoffmann-La Roche, a Swiss healthcare company, is involved in obesity-related research, contributing to medical advancements.

### Related Conditions
Obesity is related to overnutrition, a condition where nutrient intake exceeds requirements. It also includes subtypes such as morbid obesity, childhood obesity, and abdominal obesity, each with unique health implications. Obesity in pets is another related condition, affecting animals similarly.

### Significance in Medicine
Obesity is a significant medical condition studied within the academic discipline of medicine. Researchers like John Yudkin have contributed to its understanding. Organizations such as Hoffmann-La Roche play a role in developing treatments and interventions, highlighting the condition’s importance in public health.

## References

1. Disease Ontology
2. Human Phenotype Ontology release 2018-03-08
3. Nuovo soggettario
4. Freebase Data Dumps. 2013
5. Integrated Authority File
6. BBC Things
7. NDF-RT
8. [Inxight: Drugs Database](https://drugs.ncats.io/drug/0QJF08GDPE)
9. [Inxight: Drugs Database](https://drugs.ncats.io/drug/578H0RMP25)
10. [Inxight: Drugs Database](https://drugs.ncats.io/drug/NHW07912O7)
11. [Source](https://www.sciencealert.com/weight-loss-drugs-like-ozempic-can-leave-lasting-damage-in-your-mout)
12. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=266722)
13. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=26009)
14. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=2780)
15. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=115)
16. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=79068)
17. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=627)
18. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=7021)
19. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=9369)
20. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=2696)
21. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=25970)
22. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=5607)
23. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=158038)
24. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=2119)
25. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=57521)
26. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=253559)
27. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=57620)
28. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=4430)
29. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=1635)
30. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=91351)
31. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=55243)
32. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=117579)
33. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=22898)
34. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=6857)
35. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=85415)
36. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=10371)
37. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=9933)
38. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=10665)
39. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=1761)
40. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=92285)
41. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=23072)
42. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=92521)
43. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=25836)
44. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=84900)
45. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=64478)
46. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=9734)
47. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=5930)
48. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=5305)
49. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=2524)
50. [Phenocarta](https://gemma.msl.ubc.ca/phenotypes.html?phenotypeUrlId=DOID_9970&ncbiId=255119)